The Rise of Non-Tuberculosis Mycobacterial Lung Disease

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Non-tuberculous mycobacterial (NTM) infections, once considered rare, are rising globally.
• Previously thought to affect only the immunocompromised or those with lung issues, NTM now impacts healthy populations via pulmonary routes.
• NTM infections are increasingly antibiotic-resistant and spreading through human contact.

Purpose of the Study:

• To review the global disease burden and economic impact of NTM infections.
• To identify at-risk populations and current treatment strategies for NTM disease.
• To explore host-bacterial interactions, immune responses, and future research priorities for NTM.

Main Methods:

• Literature review of global NTM disease incidence and mortality.
• Analysis of risk factors, including environmental and climate change influences.
• Synthesis of current treatment options and emerging research findings.

Main Results:

• NTM disease incidence and mortality are increasing worldwide.
• Pulmonary NTM infections are rising in seemingly immunocompetent individuals.
• Antibiotic resistance and person-to-person transmission are significant concerns.
• Climate change is expanding tropical regions, likely increasing NTM prevalence.

Conclusions:

• NTM disease represents a significant and escalating global health challenge.
• Effective treatment strategies are hampered by antibiotic resistance and limited understanding of host-pathogen dynamics.
• Further research into NTM pathogenesis, transmission, and novel therapies is critical, particularly in the context of climate change and expanding endemic regions.